Implantable Collamer Lens (ICL) implantation
Eye Care
estimated about CNY 30000-45000
Disclaimer: This site is a medical service platform; some page content is AI-assisted. Health-related information does not constitute medical advice. If you have any questions, please consult a healthcare professional. See full disclaimer
Description
A refractive surgical procedure involving the insertion of a phakic intraocular lens into the eye without removing the natural crystalline lens, used to correct myopia, hyperopia, or astigmatism.
Main Uses
Primary clinical use is correction of moderate-to-high myopia (−3.00 D to −18.00 D), hyperopia (+3.00 D to +10.00 D), and astigmatism (up to −6.00 D) in patients unsuitable for LASIK/SMILE due to thin corneas, dry eyes, or high refractive error. It is a reversible, additive refractive procedure preserving natural lens and corneal integrity.
Normal Range
ICL implantation is a surgical procedure, not a laboratory test with numerical values; therefore, there is no 'normal range' of quantitative indicators. Preoperative eligibility is determined by qualitative and quantitative anatomical criteria: anterior chamber depth ≥2.8 mm, endothelial cell count ≥2,000 cells/mm², stable refraction (≤0.5 D change in past year), and adequate vault (250–750 µm postoperatively). No serum or biochemical 'values' are measured.
Low Values - Possible Causes
N/A — ICL is not a diagnostic assay yielding low/high numerical results. However, preoperative contraindications that may preclude surgery include: insufficient anterior chamber depth (<2.8 mm), low endothelial cell density (<2,000 cells/mm²), narrow anterior chamber angle (<30° on gonioscopy), active uveitis, uncontrolled glaucoma, and cataract formation.
High Values - Possible Causes
N/A — ICL is not a quantitative test. 'High' values do not apply. However, relative contraindications include excessive vault (>1,000 µm) causing pupillary block or lens touch, high myopia (>−18.00 D) exceeding ICL power limits, large white-to-white corneal diameter (>13.0 mm) increasing dislocation risk, and elevated intraocular pressure postoperatively due to steroid response or angle closure.
estimated about CNY 30000-45000
Related Items
Dry Eye Syndrome Treatment
estimated about CNY 200-1000
Phacoemulsification with intraocular lens implantation
estimated about CNY 8000-15000
Femtosecond laser-assisted cataract surgery (FLACS)
estimated about CNY 12000-22000
YAG laser capsulotomy
estimated about CNY 800-1500
Intravitreal injection of ranibizumab
estimated about CNY 5500-6500
Intravitreal injection of conbercept
estimated about CNY 3500-4500